baber/WOPTO huggingface dataset:
Patent JP-2873252-B2 (JP)
IPC: B65D51/20
Filed: 1990-01-17
Granted: 1999-03-24
Abstract: An easily removable innerseal for a container and method of application relates to an improved arrangement having a body portion (22) adapted for fitting over the upper rim of a container and a flexible element (24) attached to the body portion for a user to grip. The body portion is provided with a lower bonding layer, which includes a first bonding portion (26) and a second bonding portion (28) adhered to the first portion, and a layer (30) to prevent fluid from passing therethrough. The bonding force between the first and second bonding portions is designed to be weaker than the bonding force between the bonding layer and the container. In addition, the rupture strength of the first bonding portion is less than either of the bonding forces. As a result, the force required to remove the innerseal from the container is not dependent upon the amount of heat applied during sealing, because delamination will occur between the two bonding portions in an area over the container rim (14), leaving a residue of the first adhesive portion attached to the rim. By gripping the flexible element and pulling it upwardly, a user can remove the innerseal from the container without having to puncture or scrape the innerseal with a sharp object, which is frequently required to remove innerseals of the type commonly in use today. The method of application includes the steps of applying the body portion of the innerseal around the rim portion of a container and passing the container through an induction type heating station.
Patent JP-H085176-B2 (JP)
IPC: B41F5/24
Filed: 1988-09-28
Abstract: PCT No. PCT/DE88/00597 Sec. 371 Date Oct. 30, 1989 Sec. 102(e) Date Oct. 30, 1989 PCT Filed Sep. 28, 1988 PCT Pub. No. WO89/02824 PCT Pub. Date Apr. 6, 1989.A flexographic printing machine has a printing block cylinder, an impression cylinder and a duct roller that is immersed in an ink trough. The printing block cylinder is rotatably supported by exchangeable bearing blocks that are removably secured to spaced support beds. Each support bed is mounted on an eccentric having a journal which is carried by side plates of the printing machine. The support beds are movable both horizontally and vertically to shift the printing block cylinder between various positions.
Patent JP-3179110-B2 (JP)
IPC: H04M15/00
Filed: 1995-08-15
Granted: 2001-06-25
Abstract: PCT No. PCT/FI95/00428 Sec. 371 Date Feb. 18, 1997 Sec. 102(e) Date Feb. 18, 1997 PCT Filed Aug. 15, 1995 PCT Pub. No. WO96/06396 PCT Pub. Date Feb. 29, 1996A method and arrangement for storing on tape information produced by a switching exchange system, by reading data into an intermediate file for increasing the number of records to be stored to an amount suitable for the capacity of the recorder used; copying the intermediate file into a backup storage; and emptying the intermediate file to a tape for a new read cycle of information produced by the switching exchange system.
Patent JP-4194113-B2 (JP)
IPC: A61K47/48
Filed: 1994-10-26
Granted: 2008-12-10
Abstract: PCT No. PCT/US94/12232 Sec. 371 Date Apr. 26, 1996 Sec. 102(e) Date Apr. 26, 1996 PCT Filed Oct. 26, 1994 PCT Pub. No. WO95/11694 PCT Pub. Date May 4, 1995Conjugated compounds which comprise an ST receptor binding moiety and a radiostable active moiety are disclosed. Pharmaceutical compositions comprising conjugated compound which comprises an ST receptor binding moiety and a radiostable active moiety or an ST receptor binding moiety and a radioactive active moiety are disclosed. Methods of treating an individual suspected of suffering from metastasized colorectal cancer are disclosed. Methods of radioimaging metastasized colorectal cancer cells are disclosed. In vitro methods, kits and reagents are disclosed for determining whether or not an individual has metastasized colorectal cancer cells, for determining whether tumor cells are colorectal in origin and for analyzing tissue samples from the colon tissue to evaluate the extent of metastasis of colorectal tumor cells.
Patent JP-3041051-B2 (JP)
IPC: C07D211/56
Filed: 1996-10-02
Granted: 2000-05-15
Abstract: The present invention relates to a method for inhibiting a neurogenic inflammation caused or potentiated by an administration of viral vectors in gene therapy by administering to said mammal an antagonist that binds to a NK-1 receptor in an amount that is effective to inhibit said neurogenic inflammation.
Patent JP-2849214-B2 (JP)
IPC: A61K45/06
Filed: 1993-12-20
Granted: 1999-01-20
Abstract: The present invention relates to a therapeutic combination therapy involving the use of human interferon. The therapy involves the treatment of conditions susceptible to treatment with human interferon, with a combination of a human interferon and a free radical scavenger or precursor or inducer.
Patent JP-3467779-B2 (JP)
IPC: B01D67/00
Filed: 1997-12-01
Granted: 2003-11-17
Abstract: A filter medium which has an average pore diameter of more than 0.5 mu m, a pressure loss of 2-50 mmH2O determined when air is permeated therethrough at a velocity of flow of 5.3 cm/sec, and a PF value of 18-12, which is calculated in accordance with the following equation on the basis of this pressure loss and a collection efficiency using DOP of a grain size of 0.10-0.12  mu m. <MATH>   <IMAGE>
Patent JP-3884484-B2 (JP)
IPC: A61K47/48
Filed: 1997-11-17
Granted: 2007-02-21
Abstract: Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or negatively charged therapeutic agent and a charged molecule of opposite charge for drug delivery to the pulmonary system, and methods for their synthesis and administration are provided. In a preferred embodiment, the particles are made of a biodegradable material and have a tap density less than 0.4 g/cm<3> and a mass mean diameter between 5  mu m and 30  mu m, which together yield an aerodynamic diameter of the particles of between approximately one and three microns. The particles may be formed of biodegradable materials such as biodegradable polymers. For example, the particles may be formed of poly(lactic acid) or poly(glycolic acid) or copolymers thereof. Alternatively, the particles may be formed solely of a therapeutic or diagnostic agent and a surfactant. Surfactants can be incorporated on the particule surface for example by coating the particle after particle formation, or by incorporating the surfactant in the material forming the particle prior to formation of the particle. Exemplary surfactants include phosphoglycerides such as dipalmitoyl phosphatidylcholine (DPPC). The particles can be effectively aerosolized for administration to the respiratory tract to permit systemic or local delivery of wide a variety of therapeutic agents. Formation of complexes of positively or negatively charged therapeutic agents with molecules of opposite charge can allow control of the release rate of the agents into the blood stream following administration.
Patent JP-3307399-B2 (JP)
IPC: A61B17/56
Filed: 1996-04-17
Granted: 2002-07-24
Abstract: PCT No. PCT/SE96/00490 Sec. 371 Date Jul. 9, 1996 Sec. 102(e) Date Jul. 9, 1996 PCT Filed Apr. 17, 1996 PCT Pub. No. WO96/36285 PCT Pub. Date Nov. 21, 1996The invention relates to a drill guide instrument and method for guiding a drill tool (24) when drilling a longitudinal bore (4) through the neck (collum femoris) (5) of a human femur (9), subsequent to resection of the head (caput) (8) of the collum (5) along a cutting plane (P). The instrument comprises a drill guide (20), which is provided with a base member (21) and arranged to guide the drill tool (24) along a drill axis (B-B) relative to the base member (21), said base member (21) being intended to be applied against a cut end surface (11) of the collum (5) defining the cutting plane (P) for obtaining a predetermined orientation of the drill axis (B-B) relative to the cutting plane (P). A positioning member (22) extending from the drill guide (20) is intended to be contacted with the periphery of the narrowest portion (13) of the collum (5) in at least two circumferentially-spaced contact positions (30), so as to locate the drill axis (B-B) at a minimum distance from the periphery of said narrowest portion (13) of the collum (5). The invention also relates to the use of the instrument for performing such drilling.
Patent JP-4012568-B2 (JP)
IPC: B01J27/10
Filed: 1996-05-17
Granted: 2007-11-21
Abstract: The present invention refers to a process for the preparation of 5-amino-2,4,6-triiodo-1,3-benzenedicarboxylic acid, comprising the following steps: a) catalytic hydrogenation of 5-nitro-1,3-benzenedicarboxylic acid in neutral or basic environment, which gives an aqueous solution of 5-amino-1,3-benzenedicarboxylic acid sodium salt; b) direct iodination of the 5-amino-1,3-benzenedicarboxylic acid sodium salt solution deriving from step a), without further purification, with a solution of ICl in HCl, being the 5-amino-1,3-benzenedicarboxylic acid sodium salt solution previously added with HCl and H2SO4.
Patent JP-4198759-B2 (JP)
IPC: A61F2/86
Filed: 1998-03-06
Granted: 2008-12-17
Abstract: A wire frame stent and stent delivery system for inserting the stent into the body.
Patent ES-2323355-B2 (ES)
Title: Metodo para incrementar la potencia electrica neta de centrales termosolares.
Inventor: BLAZQUEZ GARCIA FRANCISCO
IPC: F01K13/00
Filed: 2009-04-16
Granted: 2011-01-04
Abstract: Método para incrementar la potencia eléctrica
neta de centrales termosolares. 
     La presente invención permite incrementar la
potencia  eléctrica neta suministrada a la red por las
centrales termosolares, al disminuir el consumo eléctrico de los
servicios auxiliares, de forma que se accionan las bombas
principales de servicios auxiliares con turbinas de vapor
(turbobombas) directamente utilizando energía térmica 
producida en la central. Por un lado se aprovecha la energía térmica
directamente para alimentar los servicios auxiliares en los días que
la radiación solar es mayor que la radiación de diseño ya que el
generador y la turbina no pueden sobrepasar su potencia asignada y
se debe reducir la producción térmica, ante la imposibilidad de
transformar dicha energía en energía eléctrica. Por otra parte el
rendimiento del accionamiento de las bombas de servicios auxiliares
es mejor al utilizar vapor para accionar las bombas a través de una
turbina de vapor (turbobombas) en lugar de accionarlas con motores
eléctricos (motobombas).
Patent AU-2001287886-B2 (AU)
Title: Lining ducts
Inventor: TURNER MATTHEW RICHARD
IPC: F16L58/10
Filed: 2001-09-19
Granted: 2006-06-01
Abstract: Apparatus for converting a flexible liner 2 including a layer 3 of composite material comprising thermoplastics material and reinforcing fibres, into a structural member within a duct 1, has a front portion 6 for insertion in the liner 2, a central portion 7 for heating one side of the layer 3 and a rear portion 20 which forces the heated layer 3 against the duct 1 for consolidation and cooling under pressure. The central portion 7 has heating means 8 producing hot gas which is forced under pressure through the layer 3 of composite material to heat the layer 3, and provides an air gap 14 on the opposite side of the layer 3 while heating takes place. This ensures uniform heating of the layer 3, to melt the thermoplastics material which then mixes intimately with the reinforcing fibres, and is consolidated and cooled to form the structural member.
Patent AU-2002212418-B2 (AU)
Title: Tubular support for setting, by percutaneous route, a substitution cusp
Inventor: SEGUIN JACQUES
IPC: A61F2/24
Filed: 2001-10-19
Granted: 2006-03-30
Abstract: The invention concerns a support (1) comprising a structure adapted to be radially contracted to enable the insertion of the support (1)/valve (2) assembly into the patient's body, and to be unfolded to enable said structure to be supported against the wall of the site to be equipped with the cusp. The invention is characterised in that the support structure comprises: an axial portion (3) supporting the cusp (2), having a thread or thread network structure adapted to be supported against the cardiac ring (10) remaining after removal of the deficient native cusp: at least an axial wedging portion (4), having a thread or thread network structure separate from the structure of said axial portion (3) of the cusp support, and with a diameter greater than the diameter of said axial portion (3) enabling it to be supported against the wall bordering said remaining cardiac ring (10); at least a thread (5) linking point-to-point said portions (3, 4).
Patent AU-2002334135-B2 (AU)
Title: Antibodies against KDR, their production and uses
Inventor: ZINKEWICH-PEOTTI KAREN
IPC: C12N5/10
Filed: 2002-10-10
Granted: 2009-01-08
Abstract: There are disclosed antibody molecules containing at least on CDR derived from a mouse monoclonal antibody having specificity for human KDR. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a hybrid CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases in which VEGF and/or KDR are implicated.
Patent AU-2003249578-B2 (AU)
Title: Process for preparation of non-hazardous brominating agent
Inventor: SUBBARAYAPPA ADIMURTHY
IPC: C01B11/20
Filed: 2003-05-30
Granted: 2007-12-06
Abstract: A cost-effective process is described for the preparation of a stable and non-hazardous brominating reagent containing 2:1 stoichiometric ratio of alkali bromide to alkali bromate. The process comprises of reacting alkaline bromine intermediate mixture, obtained from bromine recovery plant, with chlorine gas in the presence of a strong alkali to oxidize the bromide ions to bromate ions. This brominating reagent is useful for the bromination of aromatic compounds by substitutions.
Patent AU-2003250524-B2 (AU)
Title: Apparatus and method for erasing road lane markings
Inventor: MANOR ZAMIR
IPC: E01C23/088
Filed: 2003-08-20
Granted: 2008-01-17
Abstract: An apparatus for erasing a road marking on a road lane comprising a chassis adapted to travel over the road lane; a heating source mounted to the chassis for directly or indirectly applying heat to the road marking; and a positively driven rotatable brush mounted to the chassis. The brush has bristles contactable with the road marking and adapted for removing it, when heated, from the road. Indirect heating of the road marking can be accomplished by first heating the bristles of the brush.
Patent AU-2004312573-B2 (AU)
Title: Lighting fixture closing mechanism
Inventor: ENGEL HARTMUT S
IPC: F21V21/04
Filed: 2004-11-26
Granted: 2009-03-19
Abstract: The invention relates to a lighting unit, in particular a lighting fixture for ceilings and/or walls comprising a coupled housing frame (2) and a functional frame (3) which is pivotally mounted with respect to the housing frame. A closing device is provided between the housing and functional frames and consists of a specially shaped wire spring (4) which interacts with the rest reception area (10) of the functional frame (3) and comprises a spring leg (8) interacting with the functional frame (3) in a predefined pivoting area under a preload effect.
Patent AU-2005202026-B2 (AU)
Title: Lateral support for an operating table
Inventor: COPELAND JOHN ROBERT
IPC: A61G13/12
Filed: 2005-05-12
Granted: 2012-02-16
Abstract: - 12 A patient positioning support for an operating theatre table 2 has a saddle 18 for clamping to the rail 8 which runs alongside the edge of the table and a pair of articulating arms 26, 5 32 attached to the saddle for holding a pad in contact with a patients body or limb. The devices are mounted in pairs and are lockable in positions which overlie the table or lie outboard of the table or below the table when not required. The locking action is by friction but radial arrays of teeth 66, 68, which are locked by hand screws 62, give the preferred locking action. Other items of equipment such as arm boards, neural head supports and stirrups can be substituted for the pad. OFi '000 m 00
Patent AU-2005208721-B2 (AU)
Title: Releasably-securable one-piece adjustable gastric band
Inventor: BIRK JANEL
IPC: A61B17/08
Filed: 2005-01-21
Granted: 2010-09-23
Abstract: A releasably-securable gastric band having a tail end and a head end for receiving the tail end is disclosed. The gastric band also includes a releasable locking means that releasably secures the head and tail ends together. The tail end may include a tooth and the head end may include a notch for engaging the tooth. Upon insertion of the tail end finto the head end, the tooth mates with the notch and releasably locks the tail end in the head end. The releasably-securable gastric band also includes a release tab. When force is applied to the release tab in a direction perpendicular to a central axis of the gastric band, the tooth is disengaged from the notch to allow the gastric band to be released.
Patent AU-2005254072-B2 (AU)
Title: High sound attenuating hearing protection device
Inventor: FALCO ROBERT N
IPC: A61F11/08
Filed: 2005-06-13
Granted: 2011-08-25
Abstract: A hearing protection device insertable into an earcanal is provided, the device generally including a stem portion, a sound attenuating portion affixed to and extending at least partially over the stem portion, and a volume of space disposed between and delimited by the sound attenuating portion and the stem portion, where at least a part of the sound attenuating portion is collapsible into the volume of space during insertion of the hearing protection device into the earcanal.
Patent AU-2005277822-B2 (AU)
Title: Display and method of operation
Inventor: WILLIAMS JOHN S
IPC: G09F9/33
Filed: 2005-07-27
Granted: 2009-01-29
Abstract: A sign structure having a display, movable member and computer means creates a unique vehicle for displaying content. In one version, the movable member is adjacent to the display and substantially shields a portion of the display as it traverses thereover. Coordinated content transmitted to the display gives the appearance that the movable member is influencing the displayed content. For example, as the member moves upward an image below the member stretches in size while an image above the member compresses in size until the upper image disappears and the lower image occupies the entire visible portion of the display. This continues as the member traverses up and down over the display. The member may appear to manipulate the images by stretching, compressing, pushing, pulling and/or erasing them.
Patent AU-2005287502-B2 (AU)
Title: Immunogenic composition for use in vaccination against staphylococcei
Inventor: FERNAND LECRENIER NICOLAS PIERRE
IPC: A61P31/04
Filed: 2005-09-20
Granted: 2011-12-01
Abstract: The present application relates to immunogenic compositions comprising a mixture of staphylococcal antigens which combines antigen having different functions, for instance, combinations including a staphylococcal extracellular component binding protein and a staphylococcal transporter protein or a staphylococcal extracellular component binding protein and a staphylococcal regulator of virulence or toxin or a staphylococcal transporter protein and a staphylococcal regulator of virulence or toxin. Vaccines, methods of treatment, uses of and processes to make a staphylococcal vaccine are also described.
Patent AU-2005305083-B2 (AU)
Title: GPR41 and modulators thereof for the treatment of insulin-related disorders
Inventor: CHU ZHI LIANG
IPC: G01N33/50
Filed: 2005-11-01
Granted: 2012-02-02
Abstract: The present invention relates to a method for identifying a glycemic stabilizing compound by: a) contacting a candidate compound with GPR41, and b) determining whether GPR41 functionality is modulated, where a modulation in GPR41 functionality is indicative of the candidate compound being a glycemic stabilizing compound. In addition, the invention relates to a method for identifying a glycemic stabilizing compound, comprising: a) contacting a candidate compound with GPR41, and b) determining whether GPR41 functionality is increased, wherein an increase in GPR41 functionality is indicative of the candidate compound being a glycemic stabilizing compound. Further, the invention relates to a method for identifying a glycemic stabilizing compound, comprising: a) contacting a candidate compound with GPR41, and b) determining whether GPR41 functionality is decreased, wherein a decrease in GPR41 functionality is indicative of the candidate compound being a glycemic stabilizing compound.
Patent AU-2005321469-B2 (AU)
Title: Lipid complexes coated with peg and their use
Inventor: KAUFMANN JOERG
IPC: C12N15/113
Filed: 2005-12-27
Granted: 2012-04-05
Abstract: The present invention is related to a lipid composition comprising at least a first lipid component, at least a first helper lipid, and a shielding compound which is removable from the lipid composition under in vivo conditions.
Patent AU-2005324348-B2 (AU)
Title: Method and apparatus for chromosome profiling
Inventor: VALLABHANENI RAMESH
IPC: C12Q1/68
Filed: 2005-12-22
Granted: 2011-09-01
Abstract: A method and apparatus for generating an Interphase chromosome profile. The method comprises obtaining a sample containing cells having chromosomes for profiling; obtaining species specific DNA probes, wherein the DNA probes are capable of marking at least one chromosome at substantially equidistant locations on said chromosomes; hybridizing the sample with the DNA probes; using a plurality of enzymes to produce differential color bands on the chromosome for colorimetric analysis of the sample; and using visual analysis for determining the profile of the chromosome.
Patent AU-2006223191-B2 (AU)
Title: Method of improving control information acquisition latency by transmitting control information in individually decode-able packets
Inventor: RADHAKRISHNAN DHINAKAR
IPC: H04L12/56
Filed: 2006-03-10
Granted: 2010-09-30
Abstract: Provided is a method and system for enhancing acquisition latency in a communications network. The method includes identifying control information associated with transmitted information and fragmenting the identified control information. Each fragment of control information is then associated with a corresponding transmission unit of the transmitted information. This process facilitates independent decoding and processing of the control information, which is embedded within physical layer packets.
Patent AU-2006254106-B2 (AU)
Title: Use of IL-18BP isoforms for the treatment and/or prevention of neurological inflammatory diseases
Inventor: CHVATCHKO YOLANDE
IPC: A61P25/00
Filed: 2006-06-02
Granted: 2012-04-26
Abstract: The invention relates to the use of an IL18-BP isoform that does not bind to IL18, or of an agonist thereof, for treatment or prevention of a neurological and/or inflammatory disease. Preferred isoforms for use in the frame of the present invention include IL-18BPb and IL-18BPd.
Patent AU-2006256859-B2 (AU)
Title: Diagnostic-nanosensor and its use in medicine
Inventor: SCHAFER AXEL
IPC: G01N21/55
Filed: 2006-06-09
Granted: 2012-05-31
Abstract: This invention relates generally to biosensor technology, and pertains more particularly to novel multifunctional biosensors based on ordered arrays of metallic, semiconductors and magnetic nano-islands for medical, biological, biochemical, chemical and environmental applications.
Patent AU-2006298882-B2 (AU)
Title: Novel sulphonylpyrroles as inhibitors of HDAC S novel sulphonylpyrroles
Inventor: ROLF-PETER HUMMEL
IPC: A61K31/4015
Filed: 2006-09-08
Granted: 2011-10-27
Abstract: Compounds of a certain formula (I), in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, as well as salts thereof are novel effective HDAC inhibitors.